COVAX

Africa’s most populous country, Nigeria, and other countries across the continent and beyond that qualify to enjoy support from Gavi, the Vaccine Alliance will benefit from the final approval of the United States’ commitment to provide Gavi with US$ 4 billion in COVID-19 supplemental funding. These resources, which were included in a larger omnibus funding package, will ensure that lower-income economies have equitable access to safe and effective COVID-19 vaccines, helping to end the acute phase of the pandemic. In a statement, Gavi